Results 41 to 50 of about 18,252,794 (250)

Dopaminergic Pathway Genes Influence Adverse Events Related to Dopaminergic Treatment in Parkinson's Disease

Frontiers in Pharmacology, 2019
Dopaminergic pathway is the most disrupted pathway in the pathogenesis of Parkinson's disease. Several studies reported associations of dopaminergic genes with the occurrence of adverse events of dopaminergic treatment.
Sara Redenšek, Dušan Flisar, Maja Kojović, Milica Gregorič Kramberger, Dejan Georgiev, Zvezdan Pirtošek, Maja Trošt, Vita Dolžan   +7 more
doaj   +1 more source

Central Nervous System Tumors Among Infants in Canada: A Report From CYP‐C

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Central nervous system (CNS) tumors in infants are rare, pose unique clinical challenges, and lack large‐scale evidence‐based data to guide management. This study seeks to describe CNS tumors in Canadian infants and to compare their outcomes with those of older children.
Samuel Sassine, Hallie Coltin, Sylvia Cheng, Lucie Lafay‐Cousin, Vanan Issai Magimairajan, Craig Erker, Stéphanie Vairy, Lynette Bowes, Adam Fleming, Donna Johnston, Sarah McKillop, Roona Sinha, Julie Bennett, Christina Coleman, Laura Wheaton, Shayna Zelcer, Samuele Renzi, Thai Hoa Tran   +17 more
wiley   +1 more source

Design of a retrospective patient record study on the occurrence of adverse events among patients in Dutch hospitals [PDF]

, 2009
Background: Various international studies have shown that a substantial number of patients suffer from injuries or even die as a result of care delivered in hospitals.
van der Wal Gerrit, Bruijne, M.C. de, Maurits W van Tulder, Asscheman Henk, van Tulder Maurits W, Waaijman, Roelof, Waaijman, R., de Bruijne, M.C., Asscheman, Henk, van der Wal, Gerrit, Zegers Marieke, Hoonhout, L.H.F., Peter Spreeuwenberg, Spreeuwenberg, Peter, Tulder, M.W. van, van der Wal, G., Wal, Gerrit van der, de Bruijne, Martine C., Marieke Zegers, Hoonhout Lilian HF, Lilian HF Hoonhout, Cordula Wagner, Wal, G. van der, Wagner, C., van Tulder, M.W., Wagner, Cordula, Zegers, H.W.M., Gerrit van der Wal, Martine C de Bruijne, Henk Asscheman, Groenewegen, Peter P., Spreeuwenberg Peter, de Bruijne Martine C, Zegers, M., Roelof Waaijman, Wagner Cordula, Spreeuwenberg, P., van Tulder, Maurits W., Hoonhout, Lilian H. F., Waaijman Roelof, Zegers, Marieke, Asscheman, H., Bruijne, Martine C. de, van Tulder, M.W.; id_orcid   +43 more
core   +4 more sources

Chimeric Antigen Receptor T-Cell Therapy Is Associated with Low Absolute Rates of Orofacial Adverse Events and Significantly Less When Compared to Hemopoietic Stem Cell Therapy

Dentistry Journal
Background/Objectives: Chimeric antigen receptor T-cell (CAR-T) therapy has been approved for the management of relapsed and refractory hematologic malignancies, transforming the oncologic landscape and producing durable remissions in patient populations
Stella O. Oyewole, Emma Butler, Sagun D. Goyal, Adepitan A. Owosho   +3 more
doaj   +1 more source

Impact of Radiation Therapy on Physical and Psychosocial Health of Adolescents and Young Adults: A Joint Report From the Children's Oncology Group AYA and Radiation Oncology Committees

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Rates of cancer among adolescents and young adults (AYA), age 15–39 years, are increasing. Consequently, radiation oncologists are treating more AYAs who have diagnoses spanning both pediatric and adult practices. Compared to pediatric and older adult patients, AYAs face a unique set of challenges.
Hesham Elhalawani, Rachel K. Peterson, Avani D. Rao, Laurie J. McKenzie, Ahmed Magdy Elmotayam, Leslie Chang, Michael Roth, Susan L. McGovern   +7 more
wiley   +1 more source

Pediatric Idiopathic Multicentric Castleman Disease Is Often Severe But Responsive to Siltuximab

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Idiopathic multicentric Castleman disease (iMCD) is a potentially fatal immunologic disorder marked by widespread lymphadenopathy and inflammation. Siltuximab, an interleukin‐6 (IL‐6) inhibitor, is the only FDA‐approved treatment for adult patients with iMCD.
Bridget Austin, Sheila K. Pierson, Kelley C. Dacus, Mateo Sarmiento Bustamante, Saishravan Shyamsundar, Larissa Borys, Kayla McHugh, Abiola Irvine, Yoojin Jo, Adam Bagg, Mary Jo Lechowicz, Daisy Alapat, Amy Chadburn, Megan S. Lim, Gordan Srkalovic, Frits van Rhee, David C. Fajgenbaum, Joshua D. Brandstadter   +17 more
wiley   +1 more source

Adverse event data (TEAE = treatment related adverse events; SAE = serious adverse events; N = Number of patients; M = number of events).

, 2022
Adverse event data (TEAE = treatment related adverse events; SAE = serious adverse events; N = Number of patients; M = number of events).
Lars Bruce (12634647), Lennart I. Persson (12634650), Giacomo Lazzarino (4328215), Valentina Di Pietro (5644214), Barbara Tavazzi (6432004), Zsuzsanna Nagy (64689), Giuseppe Lazzarino (6418811), Nicholas M. Barnes (12634644), Antonio Belli (3591311), Ann Logan (9361)   +9 more
core   +1 more source

The Impact of the COVID‐19 Pandemic on Childhood Cancer Survival: A Population‐Based Assessment of Survival Patterns Between 2015 and 2023 in Germany

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Numerous international studies have reported declines in new cancer diagnoses, delayed diagnoses and disruptions in cancer treatment following the implementation of COVID‐19 pandemic public health measures, raising concerns that these effects may ultimately contribute to increased cancer mortality.
Friederike Erdmann, Maike Wellbrock, Javier Louro, Arndt Borkhardt, Martin Schrappe, Claudia Trübenbach, Desiree Grabow, Cécile M. Ronckers, Joachim Schüz   +8 more
wiley   +1 more source

Treatment-related adverse events during the 188-week extension phase.

, 2016
Treatment-related adverse events during the 188-week extension phase.
Gunnar Buyse (503776), Marleen van den Hauwe (503771), Judith C. van Deutekom (632518), Anna-Karin Kroksmark (3097830), Giles Campion (3097833), Sjef J. de Kimpe (632520), Már Tulinius (3097836), Afrodite Lourbakos (632521), Rosamund J. Wilson (3097824), Nathalie M. Goemans (3097827)   +9 more
core   +1 more source

Referral Patterns and Diagnostic Timeliness in Pediatric Cancer: A Hospital‐Based Study in Indonesia

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Timely diagnosis and treatment are critical for improving survival among children with cancer. In low‐ and middle‐income countries (LMICs), delays are common and may be influenced by fragmented referral pathways and diagnostic limitations.
Nur Melani Sari, Regina Hadi Putri, Fatimah Assyifa, Judith Spijkerman, Gertjan Johannes Kaspers, Susi Susanah   +5 more
wiley   +1 more source